Cardiovascular risk factor control in antiphospholipid syndrome, and differences between primary and systemic lupus erythematosus-related antiphospholipid syndrome (SURF-SLE and APS project): a cross-sectional study of 1003 individuals from 11 countries

By afschroeder • November 23, 2025

Bolla E, Semb AG, Petri M, Sfikakis PP, Artim-Esen B, Hernandez-Molina G, Hachulla E, Direskeneli H, Karpouzas GA, Zucchi D, Goyal M, Costedoat-Chalumeau N, Tincani A, Yazici A, Lerang K, Troldborg A, Ajeganova S, Popkova TV, Svenungsson E, Pantazis N, Tektonidou MG; SURF-SLE and APS collaborators. Cardiovascular risk factor control in antiphospholipid syndrome, and differences between primary and systemic lupus erythematosus-related antiphospholipid syndrome (SURF-SLE and APS project): a cross-sectional study of 1003 individuals from 11 countries. Lancet Rheumatol. 2025 Nov 19:S2665-9913(25)00257-7. doi: 10.1016/S2665-9913(25)00257-7. Epub ahead of print. PMID: 41274305.

Tags: Harbor UCLA, Publications, Rheumatology

Pregnancy in Patients With Renal Transplant

Elali I, Nelson CK, Szymanski LM, Lemke AI, Riad SM, Hinojosa RJ, Kattah AG. Pregnancy in Patients With Renal Transplant. O G Open. 2026 May[...]

High agreement of coronary artery calcification scores between full-dose (6.5 mSv) and reduced-dose (1.5 mSv) chest computed tomography: A retrospective analysis of COPDGene

Moore JM, Pratte KA, Ferguson C, Casaburi R, Iskander B, Abbasi A, Alapati P, Chilukuri S, Narashim A, Budoff MJ, Rossiter HB. High agreement of[...]

β-Glucan chitosan particle provides cross-protection against multi-drug-resistant Candida auris

Singh S, Barbarino A, Youssef EG, Das Gupta K, Nabeela S, Gebremariam T, Alkhazraji S, Uppuluri P, Ostroff G, Ibrahim AS. β-Glucan chitosan particle provides[...]